Leslie Wise Email & Phone Number

Houston, Tx, Us

Baltimore, Maryland, Us

MedTech consulting for Device, Diagnostics and Digital

Strategic Market Access Consultancy working with medtech, life science and digital health clients to achieve successful commercialization. Led by a tenured former Medical Device Executive, deep experience working with CMS, FDA, Professional Societies, KOLs, HTAs, and International Funding agencies. Significant Accomplishments: Partnered for four years with Surgical Oncology team led by Richard Stark, former SVP and Advisor at AngioDynamics to re-engineer FDA/CMS strategy for Nanoknife to ensure commercialization success far into the future.• Device specific ICD 10 PCS codes for Irreversible Electroporation • FDA IDE/PMA Strategy for IRE in Locally Advanced Pancreatic Cancer • CMS Funded Category B IRE Clinical Trial Certified on NICE META Tool• Medtech Early Technical Assessment Tool (META) was developed to help developers understand what evidence is needed to make a convincing case to payers for their technology.Innovation Advisor for Medtech and Digital HealthMedTech Innovator, Texas Medical Center Accelerator (TMCx), JLabs

Perth, Western Australia, Au

Latham, New York, Us

Executive responsible for US and OUS reimbursement, health economics and market access for multinational corporation. Develop clinical strategies and tactics necessary to effect market access for existing and emerging medical technologies. Develop health economic outcomes research, global value dossiers, budget impact models and payer packs necessary to demonstrate value of treatment alternatives.

Warsaw, Indiana, Us

Global Product Strategy with responsibility for development of global value story with a clear focus clinical, economic, and patient outcomes. The Value story must address:Current unmet needs.Definition of size of expected addressable population.Current cost of illness of treating the disease in that country.Current budget impact of caring for that disease based on current standard of care.Proposed Value proposition for Biologics treatment that would result in good reimbursement.Identification of data and evidence gaps and plan to address those gaps through observational, secondary and primary studies.Delivery of high quality Value Dossier and/or US Payer evidence dossiers.Budget Impact Model shell by product by country for use at launch, as appropriate.

Warsaw, Indiana, Us

Lead Market Access and Reimbursement through Development of Strategic Plan, EBI Value Message and Dossier • Understanding and Communicating the Changing Healthcare and Reimbursement Environment•Overcoming the Challenges of HTA•Building Relationships with Key Payers•Engaging Healthcare Thought Leaders and Stakeholders:  HEOR  Physcians  PCORI

Warsaw, Indiana, Us

Contract, Relationship Building, Medical Policy submissions with diverse payer groups: Health plans, Medicaid, Workers comp, Cost Containment Medical Utilization, 3rd Party DME vendors. Also support regional sales team on payer policy, physician direct supply agreements, and reimbursement training.

Lawrence Township, Nj, Us

Responsible for strategic marketing of Cardiovascular/Metabolic franchise to internal Medicine physicians, Interventional Cardiologists and Hospitals in West Suburban Chicago, Launched Plavix PAD and achieved overall sales ranking of #16 Nationally in 2005.

Certificate, Entrepreneurship/Entrepreneurial Studies

Certificate, International Hta, Reimbursement And Pricing

History

Education record

Certificate, Director'S College